Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6643932 | 7472371 | I | 6643932-6 | 20091201 | 20100311 | 20100317 | EXP | LTI010A00054 | TAKEDA PHARMACEUTICALS NORTH AMERICA | 51 | YR | M | N | 20100316 | MD | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6643932 | 1013350449 | PS | ACTOS | 1 | ORAL | 30 MG (30 MG ) ORAL | Y | D | 21073 | ||
| 6643932 | 1013435910 | SS | BYETTA | 1 | |||||||
| 6643932 | 1013440667 | SS | GLUCOVANCE | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6643932 | 1013350449 | TYPE 2 DIABETES MELLITUS |
| 6643932 | 1013435910 | TYPE 2 DIABETES MELLITUS |
| 6643932 | 1013440667 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6643932 | HO |
| 6643932 | LT |
Reactions reported
| Event ID | PT |
|---|---|
| 6643932 | ATRIAL FIBRILLATION |
| 6643932 | ESCHAR |
| 6643932 | FALL |
| 6643932 | GASTRODUODENAL HAEMORRHAGE |
| 6643932 | MUSCLE NECROSIS |
| 6643932 | MYOPATHY |
| 6643932 | QUADRIPARESIS |
| 6643932 | SHOCK HAEMORRHAGIC |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6643932 | FGN |
| 6643932 | HP |
| 6643932 | OTH |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6643932 | 1013350449 | 20080901 | |||
| 6643932 | 1013435910 | 20080901 | DAY | ||
| 6643932 | 1013440667 | 20080901 |